Themes

• The european Forum on oncology will focus upon key structural questions affecting oncology in the EU:
• l How can research findings be more effectively transferred into clinical practice (translation)?
• l How can the fragmented research landscape in the EU be better organized?
• l What are the most promising organizational models for research collaboration between business and academia?
• l How can fair cost benefit analyses for innovative pharmaceutical drugs be implemented in the EU?
• l How can the infrastructure for oncology in the EU (i.e. patient data banks, clinical cancer registers, advanced laboratory diagnosis) be developed in the right direction?
• l How can we ensure that patients gain access to innovative procedures and products

Target Groups

• Healthcare policy makers in the EU Parliament and the relevant Directorates-General of the EU Commission (Health and Research)
• Members of the government and civil service in healthcare, research and science as well as commerce from various EU member states
• General managers, commercial directors, chief medical officers of all hospitals in Germany, Austria and Switzerland
• Heads of leading cancer treatment centers in Germany, Austria, Switzerland, Belgium, the Netherlands, Luxembourg, UK, Spain, Sweden, Hungary, Norway, Denmark, France and Italy
• Officers of private and public healthcare insurance from various EU member states
• Participants from the EurocanPlatform and OECI